This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Finance & Accounting for Bioscience Companies East
Delivered as a Hybrid Event
September 19-20, 2022Boston, MA

Andrew Sassine, MBA
Chief Financial Officer and Board of Director at Arcturus Therapeutics, Inc.


Andy Sassine is the Chief Financial Officer at Arcturus Therapeutics. He also serves on the Board of Directors of Nasdaq listed as ICAD Inc. ICAD Inc. is a leading provider of advanced image analysis, workflow solutions and radiation therapy for early detection and treatment of cancer. Mr. Sassine served in various positions at Fidelity Investments from 1999 to 2012, including, most recently as Portfolio Manager.
Between 2005 and 2011, he managed the Fidelity Small Cap Stock Fund, the Fidelity International Small Cap Opportunities Fund, and the Fidelity Advisor International Small Cap Opportunities Fund. Mr. Sassine joined Fidelity as a high yield research analyst, covering the Telecommunications, Satellite, Technology, Defense and Aerospace, and Restaurant Industries and in 2001, joined the international group as a research analyst covering small and mid-cap international stocks. Mr. Sassine has been a member of the Henry B. Tippie College of Business, University of Iowa Board of Advisors from 2009 to 2018. 

Mr. Sassine earned a Bachelor of Arts degree at the University of Iowa in 1987 and an MBA from the Wharton School at the University of Pennsylvania in 1993.

Andrew Sassine, MBA's Network

Agenda Sessions

  • CFO FIRESIDE CHAT ● Path to the CFO Role, Lessons on Leadership and Tackling Challenges

  • Biotech Equity Funding Models and Pathways — Venture Capital and the Public Markets

  • [CFO FIRESIDE CHAT] Path to the CFO Role, Lessons on Leadership and Tackling Challenges